Interestingly, it has previously been observed that PTEN-deficient cancer cells require the lipid kinase activity of PIK3CB for both PIK3 signaling and growth in vitro52,53, which gives additional support for that potential SL interaction. The gene discussed is PIK3CG; the disease is cancer.